In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides-Reference-Cited by-同舟云学术

In vivo reduction of hepatitis B virus antigenemia and viremia by antisense oligonucleotides

Published:2016-04 Issue:4 Volume:64 Page:781-789
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Billioud Gaetan,Kruse Robert L.,Carrillo Melissa,Whitten-Bauer Christina,Gao Dacao,Kim Aneeza,Chen Leon,McCaleb Michael L.,Crosby Jeffrey R.,Hamatake Robert,Hong Zhi,Garaigorta Urtzi,Swayze Eric,Bissig Karl-Dimiter,Wieland Stefan

Publisher

Elsevier BV

Subject

Hepatology

Reference58 articles.

1. Global epidemiology of hepatitis B virus;Custer;J Clin Gastroenterol,2004

2. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures;Lavanchy;J Viral Hepat,2004

3. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide;Perz;J Hepatol,2006

4. The replication cycle of hepatitis B virus;Urban;J Hepatol,2010

5. The role of quantitative hepatitis B serology in the natural history and management of chronic hepatitis B;Nguyen;Hepatol Int,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus;Advanced NanoBiomed Research;2024-03-25

2. Localization of unlabeled bepirovirsen antisense oligonucleotide in murine tissues using in situ hybridization and CARS imaging;RNA;2023-07-17

3. Making Sense of the Antisense Therapy for Hepatitis B – Bepirovirsen;Journal of Clinical and Experimental Hepatology;2023-05

4. A dual‐targeting near‐infrared biomimetic drug delivery system for HBV treatment;Journal of Medical Virology;2022-11-28

5. Transcriptomics and RNA-Based Therapeutics as Potential Approaches to Manage SARS-CoV-2 Infection;International Journal of Molecular Sciences;2022-09-21